Hitoo Nishi

3.2k citations
22 papers · 2.2k indexed · h-index 15
Topics
MicroRNA in disease regulation (9 papers)Atherosclerosis and Cardiovascular Diseases (4 papers)Cardiac Fibrosis and Remodeling (4 papers)

In The Last Decade

Hitoo Nishi

22 papers receiving 2.2k citations

Peers

Hitoo Nishi
Comparison fields: 5 of 94
  • Molecular Biology 1.4k
  • Cancer Research 1.1k
  • Immunology 463
  • Cardiology and Cardiovascular Medicine 355
  • Surgery 293
Replace Tsuyoshi Kadomatsu with:
Tsuyoshi Kadomatsu Japan
Mary M. Kavurma Australia
Michèle Geoffrion Canada
Luca Beltrame Italy
Yasuhide Kuwabara Japan
Astrid Wietelmann Germany
Xudong Liao United States
Ljubica Matic Sweden
Karine Tréguer France
Hitoo Nishi relative to Tsuyoshi Kadomatsu Japan Tsuyoshi Kadomatsu's profile →
Citations per field
00.5×1.5×2.2×
Tsuyoshi Kadomatsu · 1×
Citations per year

Countries citing papers authored by Hitoo Nishi

Since Specialization
Citations

This map shows the geographic impact of Hitoo Nishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoo Nishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoo Nishi more than expected).

Fields of papers citing papers by Hitoo Nishi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoo Nishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoo Nishi. The network helps show where Hitoo Nishi may publish in the future.

Co-authorship network of co-authors of Hitoo Nishi

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoo Nishi. A scholar is included among the top collaborators of Hitoo Nishi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoo Nishi. Hitoo Nishi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 34
2 221
3 25
4 12
5 39
6 260
7 14
8 11
9 14
10 478
11 164
12 1
13 74
14 132
15 11
16 127
17 155
18 25
19 108
20 1

About Hitoo Nishi

Hitoo Nishi is a scholar working on Cancer Research, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 22 papers that have together received 2.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (9 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Cardiac Fibrosis and Remodeling (4 papers). The work is most often cited by research in Cancer Research (1.1k citations), Immunology (463 citations) and Molecular Biology (1.4k citations). Hitoo Nishi has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Koh Ono, Takahiro Horie, Kazuya Nagao, Minako Kinoshita, Toru Kita, Yasuhide Kuwabara, Takeshi Kimura, Koji Hasegawa, Shin Watanabe and Yoshitaka Iwanaga. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026